GSA Capital Partners’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $245K | Sell |
2,247
-18,987
| -89% | -$1.81M | 0.02% | 1353 |
|
|
2025
Q4 | $1.72M | Buy |
21,234
+16,792
| +378% | +$1.45M | 0.15% | 125 |
|
|
2025
Q3 | $389K | Buy |
+4,442
| New | +$397K | 0.03% | 1025 |
|
|
2025
Q1 | – | Sell |
-12,869
| Closed | -$1.19M | – | 1896 |
|
|
2024
Q4 | $1.19M | Buy |
12,869
+6,223
| +94% | +$598K | 0.09% | 298 |
|
|
2024
Q3 | $617K | Sell |
6,646
-1,103
| -14% | -$95.6K | 0.05% | 782 |
|
|
2024
Q2 | $638K | Buy |
7,749
+4,029
| +108% | +$296K | 0.04% | 809 |
|
|
2024
Q1 | $247K | Sell |
3,720
-6,105
| -62% | -$377K | 0.02% | 1309 |
|
|
2023
Q4 | $558K | Sell |
9,825
-19,954
| -67% | -$1.05M | 0.05% | 728 |
|
|
2023
Q3 | $1.62M | Buy |
+29,779
| New | +$1.76M | 0.14% | 177 |
|
|
2023
Q1 | – | Sell |
-5,996
| Closed | -$276K | – | 1730 |
|
|
2022
Q4 | $276K | Sell |
5,996
-12,916
| -68% | -$605K | 0.03% | 988 |
|
|
2022
Q3 | $958K | Buy |
18,912
+3,590
| +23% | +$179K | 0.13% | 179 |
|
|
2022
Q2 | $698K | Buy |
15,322
+9,789
| +177% | +$438K | 0.1% | 303 |
|
|
2022
Q1 | $257K | Buy |
+5,533
| New | +$248K | 0.03% | 1009 |
|
|
2021
Q2 | – | Sell |
-8,623
| Closed | -$421K | – | 1480 |
|
|
2021
Q1 | $421K | Buy |
8,623
+1,745
| +25% | +$81.8K | 0.07% | 440 |
|
|
2020
Q4 | $279K | Buy |
+6,878
| New | +$246K | 0.05% | 776 |
|
|
2020
Q1 | – | Sell |
-21,612
| Closed | -$777K | – | 1329 |
|
|
2019
Q4 | $777K | Buy |
21,612
+659
| +3% | +$22.7K | 0.09% | 353 |
|
|
2019
Q3 | $716K | Sell |
20,953
-7,460
| -26% | -$238K | 0.1% | 324 |
|
|
2019
Q2 | $795K | Buy |
28,413
+2,713
| +11% | +$75.4K | 0.09% | 365 |
|
|
2019
Q1 | $797K | Sell |
25,700
-339
| -1% | -$9.05K | 0.08% | 410 |
|
|
2018
Q4 | $616K | Buy |
26,039
+3,239
| +14% | +$88.5K | 0.07% | 450 |
|
|
2018
Q3 | $883K | Buy |
22,800
+13,887
| +156% | +$500K | 0.05% | 756 |
|
|
2018
Q2 | $298K | Buy |
+8,913
| New | +$317K | 0.01% | 1392 |
|
|
2017
Q3 | – | Sell |
-27,832
| Closed | -$869K | – | 1774 |
|
|
2017
Q2 | $869K | Buy |
27,832
+11,721
| +73% | +$338K | 0.06% | 665 |
|
|
2017
Q1 | $397K | Sell |
16,111
-30,647
| -66% | -$720K | 0.02% | 1226 |
|
|
2016
Q4 | $1.19M | Sell |
46,758
-107,245
| -70% | -$2.38M | 0.07% | 468 |
|
|
2016
Q3 | $3.06M | Sell |
154,003
-18,200
| -11% | -$318K | 0.16% | 96 |
|
|
2016
Q2 | $2.46M | Sell |
172,203
-12,600
| -7% | -$193K | 0.14% | 159 |
|
|
2016
Q1 | $2.87M | Sell |
184,803
-1,100
| -0.6% | -$15.8K | 0.18% | 76 |
|
|
2015
Q4 | $3.21M | Buy |
185,903
+20,785
| +13% | +$301K | 0.16% | 106 |
|
|
2015
Q3 | $2.01M | Buy |
165,118
+130,718
| +380% | +$1.68M | 0.1% | 262 |
|
|
2015
Q2 | $415K | Buy |
+34,400
| New | +$339K | 0.02% | 1455 |
|
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
GSA Capital Partners's LMAT Position: Q1 2026 in Review
GSA Capital Partners reduced its LeMaitre Vascular (LMAT) stake by 89% in Q1 2026, selling an estimated $1.81M and leaving 2,247 shares worth $245K. The position accounts for 0.02% of the portfolio, ranked #1353.
GSA Capital Partners first reported a position in LMAT in Q2 2015 and has held it in 31 quarters since. The position peaked at $3.21M in Q4 2015. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- GSA Capital Partners held 2,247 shares of LeMaitre Vascular worth $245K as of Q1 2026.
- GSA Capital Partners sold 18,987 LeMaitre Vascular shares in Q1 2026, an estimated $1.81M.
- LeMaitre Vascular made up 0.02% of GSA Capital Partners's portfolio in Q1 2026, its #1353 holding.
- GSA Capital Partners first reported a position in LeMaitre Vascular in Q2 2015 and has held it in 31 quarters since.
- GSA Capital Partners's LeMaitre Vascular position peaked at $3.21M in Q4 2015.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.